Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic MelanomaAmanda van Vliet, Jan Spanholtz, Anna‐Maria Georgoudaki et al.|Cancers|2021Cited by 48
Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor ReceptorElisa C. Toffoli, Abdolkarim Sheikhi, Roeland Lameris et al.|Cancers|2021Cited by 22
Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tumor growth, and trigger a pro-inflammatory shift in patient-derived cultures of primary and metastatic colorectal cancerElisa C. Toffoli, Tanja D. de Gruijl, Amanda van Vliet et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 21
Boosting Natural Killer Cell Therapies in Glioblastoma Multiforme Using Supramolecular Cationic Inhibitors of Heat Shock Protein 90Tanmoy Saha, Aaron Goldman, Luu Pham et al.|Frontiers in Molecular Biosciences|2021Cited by 10
Bulk and single-cell transcriptomics identify gene signatures of stem cell-derived NK cell donors with superior cytolytic activityAmanda van Vliet, Monica Raimo, Mirjam G.C.N. van den Hout et al.|Molecular Therapy Oncology|2024Cited by 9